Eko Health Broadens Global Reach with UK Launch of AI-Powered Stethoscope Platform

April 16, 2025
2:19 pm

Eko Health, one of the global leaders in AI-enabled cardiopulmonary care, on 15th April, announced its launch in the United Kingdom—one of the world’s largest healthcare markets. UK clinicians can now purchase Eko’s CORE 500 Digital Stethoscope, Eko+ Membership, and accessories through the EkoHealth website and Amazon UK, expanding access to AI-powered tools designed to support earlier detection of cardiovascular and respiratory disease.

This expansion builds on Eko’s international momentum and collaborations with UK institutions, including Imperial College London, where Eko’s technology supports earlier detection of heart disease in frontline care.

“Bringing Eko’s AI-powered technology directly to UK healthcare professionals represents an exciting step forward in expanding access to high-quality digital auscultation tools,” said David Bakey, General Manager of Consumer at Eko Health. “With CORE 500, Eko+, and a full range of accessories now available through EkoHealth official website, we’re making it easier than ever for providers to integrate advanced stethoscope technology into their practice.”

Clinicians across the United Kingdom can now access Eko’s advanced digital stethoscopes, auscultation accessories, and AI-supported tools via the official website of EkoHealth and Amazon UK. Courtesy: Eko Health website

The CORE 500 Digital Stethoscope is Eko’s most advanced auscultation device, designed to support both in-person and remote care through a suite of integrated features including three listening modes: wide, cardiac, and pulmonary, simultaneous visualization of ECG and heart sounds, active noise cancellation for clarity in busy clinics and wards, and integration with Eko’s mobile application for secure data capture and sharing

The Eko+ Membership enhances the capabilities of Eko’s stethoscopes with powerful AI features, now available to UK users through the EkoHealth website, the Apple App Store, and Google Play. Eko+ includes AI-guided detection of heart murmurs and atrial fibrillation, tachycardia and bradycardia identification, waveform visualization and guided multi-point auscultation, and secure recording and sharing to support collaborative or remote care.

Eko’s UK launch reflects rising demand for digital and AI-supported tools in general practice, urgent care, cardiology, and community settings. With over 600,000 users globally, Eko’s platform is helping clinicians detect heart and lung conditions earlier and with greater confidence.